Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1204-1210
Published online before print April 10, 2003, doi: 10.1161/01.ATV.0000071349.30914.25
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/7/1204    most recent
01.ATV.0000071349.30914.25v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, L.
Right arrow Articles by Zukowska, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, L.
Right arrow Articles by Zukowska, Z.
Related Collections
Right arrow Nutrition
Right arrow Other Ethics and Policy
Right arrow ACE/Angiotension receptors
Right arrow Catheter-based coronary and valvular interventions: other
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1204.)
© 2003 American Heart Association, Inc.


Vascular Biology

Neuropeptide Y–Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery

Lijun Li; Edward W. Lee; Hong Ji; Zofia Zukowska

From the Department of Physiology and Biophysics, Georgetown University, Washington, DC.

Correspondence to Zofia Zukowska, Department of Physiology and Biophysics, Georgetown University, 3900 Reservoir Rd NW, Box 571460, Washington, DC 20057-1460. E-mail zzukow01{at}georgetown.edu

Objective— Attempts to restore blood flow through atherosclerotic vessels by angioplasty often result in restenosis. Because the role of nerves in this process is unclear, we investigated whether neuropeptide Y (NPY), a sympathetic cotransmitter with vascular mitogenic activities, contributes to postangioplasty restenosis.

Methods and Results— Carotid artery balloon angioplasty upregulated vascular expression of NPY and its processing enzyme (DPPIV/cd26) and receptors (Y1, Y2, Y5 mRNA and protein) within 6 to 24 hours and stimulated neointima formation and accumulation of NPY in platelets after 14 days. NPY pellets (1 to 10 µg/pellet for 14 days) inserted next to the injured artery elevated platelet and vascular NPY immunoreactivity to stress-like levels and dose-dependently augmented angioplasty-induced neointima. Strikingly, 10 µg NPY for 14 days led to vessel occlusion with an atherosclerotic-like lesion, with thrombus and neointima containing neovessels, macrophages, matrix, and lipids. Y1 or Y5 receptor antagonist completely prevented the effect of NPY and reduced angioplasty-induced neointima by 50%.

Conclusions— Angioplasty upregulates platelet and vascular NPY systems, which then contribute to neointima formation via Y1 and Y5 receptor activation. Increasing NPY to high stress levels triggers formation of a thrombotic atherosclerotic-like lesion and vessel occlusion. Thus, NPY may be a risk factor for accelerated atherosclerosis, and NPY receptor antagonists may be a possible new treatment for restenosis.


Key Words: neuropeptide Y • NPY receptors • atherosclerosis • restenosis • neointima




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. H. Damon
TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C306 - C312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. Y. Callanan, E. W. Lee, J. U. Tilan, J. Winaver, A. Haramati, S. E. Mulroney, and Z. Zukowska
Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1811 - F1817.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Movafagh, J. P. Hobson, S. Spiegel, H. K. Kleinman, and Z. Zukowska
Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors
FASEB J, September 1, 2006; 20(11): 1924 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li, A.-C. Jonsson-Rylander, K. Abe, and Z. Zukowska
Chronic Stress Induces Rapid Occlusion of Angioplasty-Injured Rat Carotid Artery by Activating Neuropeptide Y and Its Y1 Receptors
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2075 - 2080.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Li, K. Tanaka, K. Morioka, T. Uesaka, N. Yamada, A. Takamori, M. Handa, S. Tanabe, and A. Ihaya
Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1
Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1370 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam
The severe cardiorenal syndrome: 'Guyton revisited'
Eur. Heart J., January 1, 2005; 26(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. G. Sobey
Neurogenic Atherosclerosis Mediated by Neuropeptide Y: Hardening of the Evidence
Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1137 - 1139.
[Full Text] [PDF]